We did not find differences in serum IGF-1, IGF-1R, AGE, RAGE or sRAGE levels in other clinical characteristics of CRC+ T2DM patients (all P > 0.05) (Table 2). The gene discussed is IGF1R; the disease is colorectal carcinoma.